Hinge Health, Inc. (HNGE) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 182.31M | 170.73M | 154.21M | 139.1M | 123.83M | 117.26M | 82.71M |
| Revenue Growth % | 47.23% | 45.6% | - | - | 49.71% | - | - |
| Cost of Goods Sold | 28.07M | 26.7M | 28.01M | 41.34M | 23.59M | 21.17M | 24.77M |
| COGS % of Revenue | 15.4% | 15.64% | 18.16% | 29.72% | 19.05% | 18.05% | 29.95% |
| Gross Profit | 154.23M | 144.03M | 126.2M | 97.76M | 100.23M | 96.09M | 57.94M |
| Gross Margin % | 84.6% | 84.36% | 81.84% | 70.28% | 80.95% | 81.95% | 70.05% |
| Gross Profit Growth % | 53.87% | 49.89% | - | - | 72.99% | - | - |
| Operating Expenses | 122.16M | 116.77M | 132.29M | 678.43M | 87.1M | 74.77M | 88.29M |
| OpEx % of Revenue | 67.01% | 68.4% | 85.79% | 487.74% | 70.34% | 63.76% | 106.75% |
| Selling, General & Admin | 91.83M | 84.02M | 100.37M | 398.47M | 63.6M | 52.4M | 58.53M |
| SG&A % of Revenue | 50.37% | 49.21% | 65.09% | 286.47% | 51.36% | 44.69% | 70.77% |
| Research & Development | 30.34M | 32.76M | 31.92M | 279.96M | 23.5M | 22.37M | 29.76M |
| R&D % of Revenue | 16.64% | 19.19% | 20.7% | 201.27% | 18.98% | 19.08% | 35.99% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | 32.07M | 27.26M | -6.09M | -580.67M | 13.14M | 21.32M | -30.35M |
| Operating Margin % | 17.59% | 15.96% | -3.95% | -417.45% | 10.61% | 18.18% | -36.7% |
| Operating Income Growth % | 144.11% | 27.84% | - | - | 143.28% | - | - |
| EBITDA | 32.07M | 28.48M | -4.83M | -579.33M | 14.44M | 21.41M | -30.26M |
| EBITDA Margin % | 17.59% | 16.68% | -3.13% | -416.49% | 11.66% | 18.26% | -36.58% |
| EBITDA Growth % | 122.08% | 32.99% | - | - | 147.72% | - | - |
| D&A (Non-Cash Add-back) | 0 | 1.22M | 1.26M | 1.34M | 1.3M | 94K | 95K |
| EBIT | 32.07M | 27.26M | -1.64M | -580.67M | 13.14M | 26.16M | -26.31M |
| Net Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 3.87M | 4.96M | 4.46M | 4.69M | 5M | 4.84M | 4.05M |
| Pretax Income | 35.94M | 32.22M | -1.64M | -575.98M | 18.14M | 26.16M | -26.31M |
| Pretax Margin % | 19.72% | 18.87% | -1.06% | -414.08% | 14.65% | 22.31% | -31.81% |
| Income Tax | 814K | 122K | 206K | -326K | 998K | -951K | 158K |
| Effective Tax Rate % | 2.26% | 0.38% | -12.58% | 0.06% | 5.5% | -3.63% | -0.6% |
| Net Income | 35.13M | 32.09M | -1.84M | -575.65M | 17.14M | 27.12M | -26.46M |
| Net Margin % | 19.27% | 18.8% | -1.2% | -413.85% | 13.84% | 23.13% | -32% |
| Net Income Growth % | 104.96% | 18.36% | - | - | 164.76% | - | - |
| Net Income (Continuing) | 35.13M | 32.09M | -1.84M | -575.65M | 17.14M | 27.12M | -26.46M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.41 | 0.37 | -0.02 | -7.38 | 1.55 | 0.35 | -0.34 |
| EPS Growth % | -73.55% | 5.71% | - | - | 555.88% | - | - |
| EPS (Basic) | 0.43 | 0.39 | -0.02 | -7.38 | 1.55 | 0.35 | -0.34 |
| Diluted Shares Outstanding | 82.39M | 84.53M | 78.86M | 78.02M | 78.02M | 78.02M | 78.02M |
| Basic Shares Outstanding | 78.62M | 79.52M | 78.86M | 78.02M | 78.02M | 78.02M | 78.02M |
| Dividend Payout Ratio | - | - | - | - | - | - | - |